drugset / Trial / NCT01574157

Investigations of the Optimum Serum Bicarbonate Level in Renal Disease.

NCT01574157

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to see if treatment with sodium bicarbonate will lower urine levels of proteins that are indicators of kidney damage in people with diabetes who also have chronic kidney disease.

Timeline

Start
2012-11-05
Primary completion
2018-05-01
Completion
2018-05-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator sodium bicarbonate Diagnostic / imaging agent 0.5 meq